156 related articles for article (PubMed ID: 33501731)
21. Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation.
Ng AP; Kauppi M; Metcalf D; Hyland CD; Josefsson EC; Lebois M; Zhang JG; Baldwin TM; Di Rago L; Hilton DJ; Alexander WS
Proc Natl Acad Sci U S A; 2014 Apr; 111(16):5884-9. PubMed ID: 24711413
[TBL] [Abstract][Full Text] [Related]
22. Selinexor-induced thrombocytopenia results from inhibition of thrombopoietin signaling in early megakaryopoiesis.
Machlus KR; Wu SK; Vijey P; Soussou TS; Liu ZJ; Shacham E; Unger TJ; Kashyap T; Klebanov B; Sola-Visner M; Crochiere M; Italiano JE; Landesman Y
Blood; 2017 Aug; 130(9):1132-1143. PubMed ID: 28630120
[TBL] [Abstract][Full Text] [Related]
23. TPO-independent megakaryocytopoiesis.
Zheng C; Yang R; Han Z; Zhou B; Liang L; Lu M
Crit Rev Oncol Hematol; 2008 Mar; 65(3):212-22. PubMed ID: 18093840
[TBL] [Abstract][Full Text] [Related]
24. Serum thrombopoietin level is not regulated by transcription but by the total counts of both megakaryocytes and platelets during thrombocytopenia and thrombocytosis.
Nagata Y; Shozaki Y; Nagahisa H; Nagasawa T; Abe T; Todokoro K
Thromb Haemost; 1997 May; 77(5):808-14. PubMed ID: 9184382
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of thrombopoiesis in thrombocytopenic disorders by simultaneous measurement of reticulated platelets of whole blood and serum thrombopoietin concentrations.
Koike Y; Yoneyama A; Shirai J; Ishida T; Shoda E; Miyazaki K; Sunaga S; Horie R; Aoki K; Koike K; Ogata I; Tahara T; Kato T; Nakahara K; Kariya T; Higashihara M
Thromb Haemost; 1998 Jun; 79(6):1106-10. PubMed ID: 9657432
[TBL] [Abstract][Full Text] [Related]
26. Continuous expression of Bcl-xL protein during megakaryopoiesis is post-translationally regulated by thrombopoietin-mediated Akt activation, which prevents the cleavage of Bcl-xL.
Kozuma Y; Kojima H; Yuki S; Suzuki H; Nagasawa T
J Thromb Haemost; 2007 Jun; 5(6):1274-82. PubMed ID: 17389006
[TBL] [Abstract][Full Text] [Related]
27. Endogenous thrombopoietin levels and effect of recombinant human thrombopoietin on megakaryocyte precursors in term and preterm babies.
Murray NA; Watts TL; Roberts IA
Pediatr Res; 1998 Jan; 43(1):148-51. PubMed ID: 9432127
[TBL] [Abstract][Full Text] [Related]
28. Activating SRC/MAPK signaling via 5-HT1A receptor contributes to the effect of vilazodone on improving thrombocytopenia.
Zhou L; Ni C; Liao R; Tang X; Yi T; Ran M; Huang M; Liao R; Zhou X; Qin D; Wang L; Huang F; Xie X; Wan Y; Luo J; Wang Y; Wu J
Elife; 2024 Apr; 13():. PubMed ID: 38573820
[TBL] [Abstract][Full Text] [Related]
29. Cadmium Suppresses Bone Marrow Thrombopoietin Production and Impairs Megakaryocytopoiesis in Mice.
Zhao Y; Zhang Y; He J; Zhai Y; Yang G; Xue P; Yao Y; He M; Qu W; Zhang Y
Toxicol Sci; 2022 Mar; 186(2):309-322. PubMed ID: 35134237
[TBL] [Abstract][Full Text] [Related]
30. [Congenital amegakaryocytic thrombocytopenia (CAMT) - a defect of the thrombopoietin receptor c-Mpl].
Germeshausen M; Schulze H; Gaudig A; Krukemeier S; Strauss G; Welte K; Ballmaier M
Klin Padiatr; 2001; 213(4):155-61. PubMed ID: 11528548
[TBL] [Abstract][Full Text] [Related]
31. Cytokines for the treatment of thrombocytopenia.
Ciurea SO; Hoffman R
Semin Hematol; 2007 Jul; 44(3):166-82. PubMed ID: 17631181
[TBL] [Abstract][Full Text] [Related]
32. Recombinant human thrombopoietin: basic biology and evaluation of clinical studies.
Kuter DJ; Begley CG
Blood; 2002 Nov; 100(10):3457-69. PubMed ID: 12411315
[TBL] [Abstract][Full Text] [Related]
33. The role and mechanism of miR-557 in inhibiting the differentiation and maturation of megakaryocytes in immune thrombocytopenia.
Wang Y; Guo Y; Zhang X; Zhao H; Zhang B; Wu Y; Zhang J
RNA Biol; 2021 Nov; 18(11):1953-1968. PubMed ID: 33586614
[TBL] [Abstract][Full Text] [Related]
34. Effect of thrombopoietin receptor agonists on the apoptotic profile of platelets in patients with chronic immune thrombocytopenia.
Mitchell WB; Pinheiro MP; Boulad N; Kaplan D; Edison MN; Psaila B; Karpoff M; White MJ; Josefsson EC; Kile BT; Bussel JB
Am J Hematol; 2014 Dec; 89(12):E228-34. PubMed ID: 25132654
[TBL] [Abstract][Full Text] [Related]
35. Miniaturized 3D bone marrow tissue model to assess response to Thrombopoietin-receptor agonists in patients.
Di Buduo CA; Laurent PA; Zaninetti C; Lordier L; Soprano PM; Ntai A; Barozzi S; La Spada A; Biunno I; Raslova H; Bussel JB; Kaplan DL; Balduini CL; Pecci A; Balduini A
Elife; 2021 Jun; 10():. PubMed ID: 34059198
[TBL] [Abstract][Full Text] [Related]
36. Hirsutine, a novel megakaryopoiesis inducer, promotes thrombopoiesis via MEK/ERK/FOG1/TAL1 signaling.
Kang Y; Lin J; Wang L; Shen X; Li J; Wu A; Yue L; Wei L; Ye Y; Yang J; Wu J
Phytomedicine; 2022 Jul; 102():154150. PubMed ID: 35569185
[TBL] [Abstract][Full Text] [Related]
37. [Thrombopoietic effect of recombinant human thrombopoietin gene transferred to mice mediated by electric pulse on normal and experimental thrombocytopenia mice].
Zang W; Wei X; Wang S; Wang D
Zhonghua Xue Ye Xue Za Zhi; 2001 Mar; 22(3):128-31. PubMed ID: 11877062
[TBL] [Abstract][Full Text] [Related]
38. Carboplatin-Induced Thrombocytopenia through JAK2 Downregulation, S-Phase Cell Cycle Arrest and Apoptosis in Megakaryocytes.
Wu YH; Chen HY; Hong WC; Wei CY; Pang JS
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682967
[TBL] [Abstract][Full Text] [Related]
39. The impact of thrombopoietin on clinical practice.
Basser R
Curr Pharm Des; 2002; 8(5):369-77. PubMed ID: 12069375
[TBL] [Abstract][Full Text] [Related]
40. IGF-1 facilitates thrombopoiesis primarily through Akt activation.
Chen S; Hu M; Shen M; Wang S; Wang C; Chen F; Tang Y; Wang X; Zeng H; Chen M; Gao J; Wang F; Su Y; Xu Y; Wang J
Blood; 2018 Jul; 132(2):210-222. PubMed ID: 29802222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
